uniQure N.V. (QURE)
NASDAQ: QURE · Real-Time Price · USD
9.75
-0.87 (-8.19%)
Apr 3, 2025, 4:00 PM EDT - Market open
uniQure Market Cap
uniQure has a market cap or net worth of $527.25 million as of April 4, 2025. Its market cap has increased by 114.85% in one year.
Market Cap
527.25M
Enterprise Value
660.72M
1-Year Change
114.85%
Ranking
Category
Stock Price
$9.75
Market Cap Chart
Since March 15, 2017, uniQure's market cap has increased from $161.10M to $527.25M, an increase of 227.28%. That is a compound annual growth rate of 15.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 3, 2025 | 527.20M | -38.75% |
| Dec 31, 2024 | 860.80M | 165.93% |
| Dec 29, 2023 | 323.70M | -69.50% |
| Dec 30, 2022 | 1.06B | 10.73% |
| Dec 31, 2021 | 958.50M | -40.38% |
| Dec 31, 2020 | 1.61B | -48.57% |
| Dec 31, 2019 | 3.13B | 190.93% |
| Dec 31, 2018 | 1.07B | 78.06% |
| Dec 29, 2017 | 603.40M | 274.55% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 734.75B |
| UnitedHealth Group | 478.58B |
| Johnson & Johnson | 374.39B |
| AbbVie | 362.98B |
| Novo Nordisk | 301.38B |
| Abbott Laboratories | 228.81B |
| AstraZeneca | 225.76B |
| Merck & Co. | 218.75B |